For investors

Trend №1 in 20 22 unique product

Reliable investment in real economy

In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon

About company

CannabeTrust

#maximum loyalty

CannaBeTrust company operates within the framework of the legislation of Uruguay, Zimbabwe and Panama due to the maximum loyalty of the legislative base of those countries.

Its products are exported to more than 14 countries of the world.

14 Button

Our products

Broad Spectrum CBD Oil

This oil contains a complex of cannabinoids, but absolutely does not contain psychoactive THC, and at the same time, cbd96 products have one of the best price tags on the world market.

Neurogan CBD Capsules

Our proprietary formulation allows us to naturally create a whole plant hemp extract that is highly concentrated in CBG and contains significant amounts of cannabinoids like CBD, CBC, CBN, and more.

Neurogan CBD Gummy Bears

Gummy Bears have all the benefits of Full spectrum CBD packaged in a fruity, delicious, gummy. Each gummy bear contains 20mg of Full Spectrum Cannabidiol. Our gummies are made in small batches in an artisan bakery from all natural ingredients.

Neurogan CBD Facial Cream

The natural qualities of cannabidiol help a healthy and glowing complexion. Only hand-selected the finest skin ingredients such as coconut oil, avocado, ginseng and aloe. Enjoy gentle hydration and a high dose of antioxidants for a brighter, brighter complexion.

Company roadmap

2019-2024

2019

2019 1 quarter

Launch company cannabetrust

First shipments of Cannabetrust to Uruguay with an 8 hectare field (clinically certified variety material (with gmp standards)

01

2019 1 quarter

2019

2019 2 quarter

Crypto
industry

Sowing and data collection to build a crypto industry given the fields

02

2019 2 quarter

2019

2019 3 quarter

Genetically study

Build domes in the field to genetically study your own high cannabinoid strains

03

2019 3 quarter

2019

2019 4 quarter

Harvest
and sale

First harvest and sale under contract to the state regulator. More than 5,000 thousand customers received Israeli medical cannabis

04

2019 4 quarter

2020

2020 1 quarter

Exhibition
of cannabis

Exhibition in Switzerland of cannabis cbd with THC 1%

05

2020 1 quarter

2020

2020 2 quarter

Company research

Exhibition in Switzerland of cannabis cbd with THC 1%

06

2020 2 quarter

2020

2020 3 quarter

License
in uruguay

Renewal of the license to grow cannabis in Uruguay

07

2020 3 quarter

2020

2020 4 quarter

Fields in uruguay

For the first time, the cbd96 variety owned by the company and received accreditation showed in the fields in Uruguay the genetic indicators of survival and product quality are 20% higher than those of medical cannabis analogues

08

2020 4 quarter

2021

2021 1 quarter

Sale of
technical hemp

Selling low THC material to Chinese partners. Sale of technical hemp won at tenders by European companies for China with a volume of 100 hectares Obtaining guarantee obligations for the purchase of seed at the rates declared with a deviation of 5% per 4000 hectares

09

2021 1 quarter

2021

2021 2 quarter

Contract
signing

Signed a contract with a GMP laboratory in Switzerland

10

2021 2 quarter

2021

2021 3 quarter

Own
brand

Creating a product line under its own brand with cannabinoid content

11

2021 3 quarter

2021

2021 4 quarter

Own
token

Creation of a project to attract investment in its own token backed by its own seed bank

12

2021 4 quarter

2022

2022 1 quarter

Cultivation
of cannabis

Obtaining licences and certificates for the cultivation of cannabis in Panama

13

2022 1 quarter

2022

2022 2 quarter

Recreational cannabis

In turn, they began to obtain a license for the cultivation of recreational cannabis in Zimbabwe

14

2022 2 quarter

2022

2022 3 quarter

Land
purchase

Land purchase in Ukraine under the bill on the legalization of medical cannabis

15

2022 3 quarter

2022

2022 4 quarter

Retail
sales

Retail sales of finished products in all EU countries

16

2022 4 quarter

2023

2023 1 quarter

Planted
fields

Deploying its own production facilities in countries where the company's fields are planted

17

2023 1 quarter

2023

2023 2 quarter

Technical cannabis

Increased technical cannabis production capacity for Asian market building materials

18

2023 2 quarter

2023

2023 3 quarter

Study of cannabinoids

Establishment of an international independent institute for the study of cannabinoids

19

2023 3 quarter

2023

2023 4 quarter

Cannabis tobacco

Joint design and development of cannabis tobacco products with the largest tobacco companies in the world

20

2023 4 quarter

2024

2024 1 quarter

Production cycle

Purchase of a plant to build capacity for a closed cannabis production cycle in all climatic conditions

21

2024 1 quarter

2024

2024 2 quarter

Research
on cancer

Contracts with institutes research on cancer

22

2024 2 quarter

2024

2024 3 quarter

Initial Public Offering

Output to IPO

23

2024 3 quarter

2024

2024 4 quarter

Medical clinics

Setting up clinics to treat cannabis-related diseases

24

2024 4 quarter

Investment opportunities

Our investment program

We offer you investment packages with different investment periods and returns.

Button
01 Seeds
earn up to
0,80% daily
02 Vega
earn up to
0,90% daily
03 Canna Hold
earn up to
1,25% daily
04 Bloom
earn up to
1% daily
05 Harvest
earn up to
1,2% daily
06 Shareholder
earn up to
1,4% daily
In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon In green gold we trust icon